Evidence map›Paper›PMID 10051633›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1999

Activation of target-tissue immune-recognition molecules by double-stranded polynucleotides.

K Suzuki, A Mori, K J Ishii, J Saito, D S Singer, D M Klinman, P R Krause, L D Kohn

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 195 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Innate Immune-Modulatory Activity ofFrontiers in endocrinology · 2020
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Role of HLA typing on Crohn's disease pathogenesis.Annals of medicine and surgery (2012) · 2015
    Article
  17. Article
  18. Article
  19. Review
  20. Sensing microbial RNA in the cytosol.Frontiers in immunology · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

K SuzukiCell Regulation Section, Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
A Mori
K J Ishii
J Saito
D S Singer
D M Klinman
P R Krause
L D Kohn
National Cancer Institute · USCenter for Biologics Evaluation and Research · USNational Institutes of Health · USNational Institute of Diabetes and Digestive and Kidney Diseases · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Abnormal expression of major histocompatibility complex (MHC) class I and class II in various tissues is associated with autoimmune disease. Autoimmune responses can be triggered by viral infections or tissue injuries. We show that the ability of a virus or a tissue injury to increase MHC gene expression is duplicated by any fragment of double-stranded (ds) DNA or dsRNA introduced into the cytoplasm of nonimmune cells. Activation is sequence-independent, is induced by ds polynucleotides as small as 25 bp in length, and is not duplicated by single-stranded polynucleotides. In addition to causing abnormal MHC expression, the ds nucleic acids increase the expression of genes necessary for antigen processing and presentation: proteasome proteins (e.g., LMP2), transporters of antigen peptides; invariant chain, HLA-DM, and the costimulatory molecule B7.1. The mechanism is different from and additive to that of gamma-interferon (gammaIFN), i.e., ds polynucleotides increase class I much more than class II, whereas gammaIFN increases class II more than class I. The ds nucleic acids also induce or activate Stat1, Stat3, mitogen-activated protein kinase, NF-kappaB, the class II transactivator, RFX5, and the IFN regulatory factor 1 differently from gammaIFN. CpG residues are not responsible for this effect, and the action of the ds polynucleotides could be shown in a variety of cell types in addition to thyrocytes. We suggest that this phenomenon is a plausible mechanism that might explain how viral infection of tissues or tissue injury triggers autoimmune disease; it is potentially relevant to host immune responses induced during gene therapy.

Indexed as

Major Histocompatibility Complex3T3 CellsAnimalsCalcium-Calmodulin-Dependent Protein KinasesCell LineDNA-Binding ProteinsDNA, ViralGene Expression RegulationGenes, MHC Class IGenes, MHC Class IIInterferon-gammaMiceNF-kappa BRatsReverse Transcriptase Polymerase Chain ReactionRNA, Double-StrandedCalcium-Calmodulin-Dependent Protein KinasesDNA-Binding ProteinsDNA, ViralEBV-associated membrane antigen, Epstein-Barr virusInterferon-gammaNF-kappa BRNA, Double-StrandedStat1 protein, mouseStat1 protein, ratSTAT1 Transcription FactorStat3 protein, mouseStat3 protein, ratSTAT3 Transcription FactorTrans-ActivatorsViral Matrix Proteins

Identifiers

PMID10051633
PMCPMC26775
OpenAlexW2088223086

What OpenQuestion holds

Texttitle and abstract
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.